Mehmet Rıza KIVANÇ, Vedat TÜRKOĞLU, Muhammet GÜLER, Zehra BAŞI

İnsan Plazma ve Eritrosit AChE’nin Çeşitli İlaçlarla in Vitro İnhibisyonu

B u çalışmada; yapısal olarak farklı olan sekiz antibiyotik sefazolin, kanamisin, gentamisin, klindamisin, ivermektin ve ampisilin ve ağrı kesicinin metamizol ve diklofenak insan eritrosit ve plazma asetilkolinesteraz AChE; EC 3.1.1.7 enzimi üzerine in vitro etkileri araştırılmıştır. Bu amaçla; farklı derişimlere sahip ilaçların neden olduğu inhibisyonu belirlemek için ilaçların IC50 ve KI değerleri hesaplandı. Asetilkolinesteraz aktivitesi spektrofotometrik olarak Ellman yöntemiyle belirlendi. Daha sonra, ilaçlara maruz kalan enzim aktivitesi ölçüldü. AChE aktivitesine karşı ilaç derişimi ve Michealis-Menten grafikleri çizildi. Son olarak, bu grafikler yardımıyla IC ve K değerleri hesaplandı. IC değerleri, plazma AChE’sine diklofenak için 1.78 x10-8 M ve eritrosit AChE’sine gentamisin için 0.85 x10-8 M olduğu belirlendi. KI değerleri ise diklofenak için 1.36 x10-8 M ve gentamisin için 1.16 x10-8 M olarak hesaplandı. Ayrıca, ivermektin, klindamisin, kanamisin, ampisilin için ICve KI değerleri elde edildi. Diklofenak, plazma AChE aktivitesi üzerine gentamisin de eritrosit AChE aktivitesi üzerine en yüksek inhibitör etkisi göstermiştir. Bulunan bu değerlerin daha önce yapılan benzer çalışmalardaki inhibisyon değerlerinden daha yüksek olduğu görülmektedir [1,2]

Anahtar Kelimeler:

Asetilkolinesteraz, enzim inhibisyonu, enzim analizi, tıbbi ilaçlar, insan eritrositi ve plazması, in vitro kinetikleri

In Vitro Inhibition of Human Plasma and Erythrocyte AChE by Various Drugs

In the present study, the in vitro effects of eight structurally different antibiotics cefazolin, kanamycin, gentamicin, clindamycin, ivermectin and ampicillin and painkiller metamizole and diclofenac on human erythrocyte and plasma acetylcholinesterase activity AChE; EC 3.1.1.7 were investigated. For this, IC50 and KI values of the drugs were calculated for determining the inhibition caused by these drugs. Acetylcholinesterase activity was determined spectrophotometrically, according to Ellman’s method. Then the enzyme activity exposed to the drugs with different concentrations was measured. AChE activity vs. drug concentration and Mihealis-Menten graphs were obtained. Lastly, IC50 and KI values were estimated from these graphs. IC50 values were estimated to be 1.78 x10-8 M of diclofenac for plasma AChE and 0.85x10-8 M of gentamicin for erythrocyte AChE. K values were 1.36 x10-8 M for diclofenac and 1.16 x10-8 M for gentamicin. Also, IC50 and KI values for ivermectin, clindamycin, kanamycin, ampicillin were obtained. Diclofenac exhibited the highest inhibitory effect on plasma AChE activity. On the other hand, gentamicin showed the highest inhibitory effect on erythrocyte AChE activity, which seems to be better for inhibition of AChE than those reported previously.

Keywords:

Acetylcholinesterase, enzyme inhibition, enzyme assay, medicinal drug, human erythrocyte and plasma, in vitro kinetics,

PDF

___

O. Danis ¸ B. Yuce-Dursun, T. Cimen, S. Demir, U. Salan, G. Yalcin, A. Ogan, Evaluation of antioxidant, radical- scavenging and acetylcholinesterase inhibitory activities of various culinary herbs cultivated in southern Turkey, Food Biochem. J., 438 (2001) 602– 611.
A. Spinedi, L. Pacini, P. Luly, A study of the mechanism by which some amphiphilic drugs affect human erythrocyteacetylcholinesterase activity, Biochem. J., 261 (1989) 569-573.
B.D. Siegfried, J.G. Scott, Properties and inhibition of acetylcholinesterase in resistant and susceptible German cockroaches (Blattellagermanica L.), Pest. Biochem. Physiol., 38 (1990) 122-129.
G.B. Principato, S. Contenti, V. Talesa, C. Mangiabene, R. Pascoloni, G. Rosi, Proprionylcholinesterase from Allobophoracalignosa, Comp. Biochem. Physiol., 94 (1989) 23–27.
B.W. Wilson, I.K. Robert, C.K. William, Cholinesterases, in Handbook of pesticide toxicology, Second edition, Academic Press, San Diego, California, USA, 967– 985, 2001
A.A. Al-Qarawi, B.H. Ali, Variations in the normal activity of esterases in plasma and liver of camels (Camelusdromedarius), cattle (Bosindicus), sheep (Ovisaries) and goats (Capra hircus), J. Vet. Med., 50 (2003) 201–203.
D. Milatovic, W.D. Dettbarn, Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat, Toxicol App. Pharmacol., 136 (1996) 20-28.
J. Massoulie, S. Bon, The molecular forms of cholinesterase and acetylcholinesterase in vertebrates, Ann. Rev. Neurosci., 5 (1982) 57-106.
D. Nachmansohn, I.B. Wilson, The enzymic hydrolysis and synthesis of acetylcholine, Adv. Enzymol. Relat. Subj. Biochem., 12 (1951) 259–339.
V. Chhajlan, D. Derr, B. Earles, E. Schmell, T. August, Purification and partial amino acid sequence analysis of human erythrocyte acetylcholinesterase, FEBS Lett., 247 (1989) 279–282.
T.A. Dutta-Choudhary, T.L. Rosenberry, Human erythrocyte acetylcholinesterase is an amphipathic protein whose short membrane-binding domain is removed by papain digestion, J. Biolog. Chem. , 259 (1984) 5653–5660.
J. Massoulie, J.P. Toutant, Vertebratecholinesterases: structure and types of interactions, Hand. Exp. Pharmacol., 86 (1998) 167–224.
J.,Massoulie, L. Pezzementi, S. Bon, E. Krejci, F.M. Vallette, Molecular and cellular biology of cholinesterases, Prog. Neurobiol., 41 (1993) 31–91.
P. Masson, O. Lockridge, Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior, Arch. Biochem. Biophys., 494 (2010) 107-120.
X. Chen, L. Fang, J. Liu, C.G. Zhan, Reaction pathway and free energy profiles for butyrylcholinesterase- catalyzed hydrolysis of acetylthiocholine, Biochem., 51 (2012) 1297–1305.
E. Giacobini, Cholinesterase inhibitors: new roles and therapeutic alternatives, Pharmacol. Res., 4 (2004) 433–440.
S. Snavely, G. Hodges, The neurotoxicity of 25. A.M. Siebela, E.P. Rico K.M. Capiotti, A.L. Piato, C.T. antibacterial agents, Ann. Intern. Med., 101 (1984) 92–104.
K.M. Chow, K.C. Hui, C.C. Szetp, Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside, Eur. J. Clin. Microbiol. Infect. Dis., 24 (2005) 649–653.
M.F. Grill, R.K. Maganti, Neurotoxic effects associated with antibiotic use: management considerations, Br. J. Clin. Pharmacol., 72 (2011) 381–393.
K. Chow, C.C. Szeto, A.C. Hui, P.K. Li, Mechanisms of antibiotic neurotoxicity in renal failure, Intern. J. Antimic. Age., 23 (2004) 213–217.
E. Edward, M.D. Morse, Toxic effects of drugs on erythrocytes, Ann. Clin. Sci., 18 (1988) 13-18.
M. Erat, M Ciftci, In vitro effects of some antibiotics on glutathione reductase from sheep liver, J. Enzym Inhib. Med. Chem., 18 (2003) 545-550.
S.O. Kayaalp, Rasyonal Tedavi Yönünden Tıbbi Farmakoloji, Hacettepe-Taş pressing, Ankara, Türkiye, 1998.
G.L. Ellman, K.D. Courtney, V. Jr. Andres, R.M. Featherstone, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol., 7 (1961) 88-95. Cusinato, T.M.A. Franco, M.R. Bogo, C.D. Bonan, In vitro effects of antiepileptic drugs on acetylcholinesterase and ectonucleotidase activities in zebraŞsh (Danio rerio) brain, Toxicol. Vitr., 24 (2010) 1279–1284.
I. Shaked, G. Zimmermann, H. Soreq, Stress-induced alternative splicing modulations in brain and periphery, Ann. New York Aca. Sci., 1148 (2008) 269– 281.
E. Milkani, C.R. Lambert, W.G. McGimpsey, Direct detection of acetylcholinesterase inhibitor binding with an enzyme-based surface plasmon resonance sensor, Anal. Biochem., 408 (2011) 212–219.
M. Stoytcheva, R. Zlatev, Bioelectrocatalytical studies of the effect of some pharmaceuticals on the acetylcholinesterase activity, Electroanalys., 8 (1996) 676-679.